Emerging Cancer Scholar Award in Brain Tumour Research

Purpose of Award

The Emerging Cancer Scholar Award in Brain Tumour Research are competitive internal awards that recognize exceptional graduate students within the Arnie Charbonneau Cancer Institute, University of Calgary, who are conducting innovative and impactful research related to the Brain Tumour Research Program research priorities, as described below. By providing financial support and encouraging pursuit of external funding, the award aims to foster the development of future research leaders and strengthen the Institute’s training environment in Cancer Research.

The Brain Tumour Research Program research priorities include:

• Understanding the molecular drivers and causes of brain tumour initiation, progression, and treatment resistance to identify new targets for brain cancer therapy
• Identifying novel brain cancer treatment strategies for translation to clinical trials
• Developing the next generation of scientists and clinical fellows focused on brain cancer
   

Eligibility Criteria

• Current full-time PhD or MSc students at the University of Calgary whose primary supervisor is a current member of the Calgary Brain Tumour Program and the Arnie Charbonneau Cancer Institute
• Fulfills the Graduate Award Competition eligibility criteria
• Citizenship: Open to all students; no citizenship restrictions

Number of Awards: Determined by available funding

Application Instructions

Applications are administered by the Graduate Award Competition (GAC), available online, through your Student Centre. Please follow all guidelines and application deadlines for the GAC.

Required Components:

• All components of the Standard GAC Award Application and CSM Harmonized Form must be completed.
• Include an eligibility statement (max. 400 words) describing how your research aligns with the purpose of the Emerging Cancer Scholar Award in Brain Tumour Research (see Purpose of Award).

Full award details and application instructions can be found in the Award Guide.